2/3/2017 Contest update
Biotechs had a decent week as the threat of drug price controls receded somewhat. At Friday’s close, the Contest median was up 5.31% YTD (vs. up 2.63% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 6.86% YTD (vs. up 3.50% YTD a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 11.49% YTD (vs. up 7.19% YTD a week ago). The Nasdaq Composite Index (NCI) closed up 5.27% YTD (vs. up 5.16% YTD a week ago).
We have a new Contest leader as TUCK’s portfolio, up 26.24% YTD, moved into first place being helped by CARA’s 20% gain for the week. JBOG’s portfolio, up 22.44% YTD, dropped to second place, with FILO’s portfolio, up 19.55% YTD, boosted to third place by both CARA and MNTA.
At Friday's close, 40 of the 48 Contest portfolios were in the green, with 21 still beating the NBI and 12 beating the SPSIBI.
The 195 Contest portfolio stock picks have an average YTD gain of 5.37% and a median YTD gain of 2.54%, with 111 of the 195 picks up for the year.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None
(All corrections, especially adjustments for splits, greatly appreciated.)
Have a safe and relaxing weekend biotechies!
Peace & good health,
Bulba
2/3/17
Rank Name Profit/Loss
1 TUCK 26,239
2 JBOG 22,436
3 FIILO 19,550
4 BIOMAV 19,492
5 GENE 19,024
6 OLIVIER 17,555
7 HAMMER 15,346
8 KMASTR 14,741
9 JACKH 13,325
10 CR17 13,147
Week's Top 5 Gainers
Symbol 1/27/17 2/3/17 Wk.%chg.
CERU 0.80 1.30 62.50%
ESPR 11.75 16.44 39.91%
MGN.DE 2.30 3.10 34.78%
ATNM 1.06 1.36 28.30%
MNTA 15.15 19.30 27.39%
Week's Worst 5 Losers
Symbol 1/27/17 2/3/17 Wk.%chg.
OCRX 2.05 0.59 -71.02%
DMTX 4.40 1.90 -56.82%
STML 10.20 6.55 -35.78%
CORI 3.870 2.890 -25.32%
ARQL 1.60 1.35 -15.63%
|
